What Is Lobomycosis? Causes, Symptoms

Lobomycosis, also known as Jorge Lobo's disease, is a rare chronic skin and soft tissue infection caused by the fungus Lacazia loboi. This condition primarily affects individuals living in tropical or subtropical regions, particularly in Central and South America. The fungus enters the skin through cuts or insect bites, leading to the development of nodules and skin lesions over time. While the exact mode of transmission is not fully understood, it is believed that the fungus resides in the environment and infects humans through contact with soil or plant material. Lobomycosis is not contagious between individuals, making it a unique fungal infection.

What Are the Symptoms of Lobomycosis

These nodules can be firm, warty, or ulcerated and may appear in clusters. The skin lesions are usually found on the arms, legs, or face but can occur anywhere on the body. In some cases, patients may experience itching or changes in skin color around the affected area. As the condition progresses, the nodules may increase in size and number, leading to disfigurement. If you notice any unusual skin growths or changes, it is important to consult a healthcare provider for proper evaluation and management.

Skin nodules or lumps that are painless and slowly growing over time. Lesions that may be discolored, ranging from red to dark brown or black. Itching or burning sensation in the affected areas of the skin. Ulceration of the nodules, leading to open sores that may be prone to infection. Potential nerve damage near the lesions, resulting in numbness or loss of sensation.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

Causes of Lobomycosis

This condition predominantly affects individuals living in tropical and subtropical regions, especially in South and Central America. The exact mode of transmission is not fully understood, but it is believed to occur through traumatic inoculation of the fungus into the skin. Risk factors for developing lobomycosis include frequent contact with moist soil or vegetation, as well as working in occupations that involve outdoor activities. Additionally, immunocompromised individuals may be more susceptible to developing the infection.

Lobomycosis is caused by the fungus Lacazia loboi entering the skin through wounds or insect bites.
Prolonged exposure to wet soil or vegetation in tropical regions can increase the risk of contracting lobomycosis.
People with weakened immune systems, such as those with HIV/AIDS, are more susceptible to developing lobomycosis.
Direct contact with infected animals, such as dolphins or armadillos, can transmit the fungus responsible for lobomycosis.
Genetic predisposition may play a role in some individuals developing lobomycosis, although further research is needed to fully understand this connection.

Types Of Lobomycosis

Localized lobomycosis manifests as solitary or clustered nodules on the skin, typically affecting the limbs and ears. This form is less severe and may remain confined to the initial site without spreading. In contrast, disseminated lobomycosis involves widespread lesions that can affect multiple areas of the body, leading to more extensive tissue involvement. Both forms are caused by the fungus Lacazia loboi and are primarily found in tropical regions.

Nodular lobomycosis is characterized by the development of raised, firm nodules on the skin.
Vegetative lobomycosis presents with cauliflower-like growths on the skin surface.
Mixed lobomycosis combines features of both nodular and vegetative forms, showing a combination of nodules and vegetative lesions.
Plaque-like lobomycosis manifests as flat, raised patches on the skin.
Cicatricial lobomycosis results in scarring and fibrosis of the affected skin areas.
Zosteriform lobomycosis appears in a dermatomal distribution resembling herpes zoster.
Unilateral lobomycosis affects only one side of the body.

Risk Factors

Lobomycosis, a rare chronic skin disease caused by the Lacazia loboi fungus, has several associated risk factors. These include living in tropical or subtropical regions, particularly in South and Central America, where the fungus is endemic. Additionally, the condition is more common in individuals who have regular contact with soil, vegetation, or water sources in these regions. People with a history of traumatic injuries or insect bites, as well as those with compromised immune systems, are also at higher risk of developing lobomycosis. Early recognition and appropriate treatment are essential in managing this condition effectively.

Prolonged contact with contaminated soil or vegetation increases the risk of acquiring lobomycosis.
Individuals living in tropical or subtropical regions, where the disease is endemic, have a higher likelihood of developing lobomycosis.
Occupational exposure to forested areas or agricultural work may predispose individuals to lobomycosis infection.
Immunosuppression, such as HIV/AIDS or use of immunosuppressive medications, can make individuals more susceptible to lobomycosis.
Poor wound care or hygiene practices can facilitate the entry of the causative fungus and lead to lobomycosis.

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Diagnosis of Lobomycosis

Lobomycosis diagnosis involves a combination of clinical evaluation, skin biopsies, and laboratory tests. Initially, a healthcare provider examines the skin lesions and takes a detailed medical history. A skin biopsy is then performed to collect a sample for pathological examination, where characteristic features of lobomycosis, such as yeast-like cells called Lobo's bodies, can be identified. Additionally, molecular tests like polymerase chain reaction (PCR) may be conducted to confirm the presence of the fungus. Imaging studies like ultrasound or MRI are sometimes used to assess the extent of tissue involvement. This comprehensive approach helps in accurately diagnosing lobomycosis and guiding appropriate treatment strategies.

Diagnosis of lobomycosis is typically made through clinical evaluation and skin biopsy.
Skin biopsy samples are examined microscopically for characteristic features of lobomycosis.
Molecular techniques like polymerase chain reaction (PCR) can help confirm the presence of L. loboi DNA.
Imaging studies such as ultrasound or MRI may be used to assess the extent of tissue involvement.
Histopathological examination can reveal granulomatous inflammation with yeast-like organisms in the affected tissues.

Treatment for Lobomycosis

Treatment options typically aim to manage symptoms and prevent disease progression. Antifungal medications, such as ketoconazole and itraconazole, are commonly used to combat the fungal infection. In some cases, surgical excision of the lesions may be necessary, especially if they are large or causing significant disfigurement. Additionally, cryotherapy and laser therapy have shown some efficacy in treating lobomycosis lesions. Close monitoring and long-term follow-up are essential to ensure the effectiveness of the chosen treatment approach and prevent relapses.

Find Our Specialists

Book Doctor Appointment